Ian Strickland

Evaluate Ltd

Evaluate provides trusted commercial intelligence and predictive analytics for the pharmaceutical industry. We help our clients to refine and transform their understanding of the past, present and future of the global pharmaceutical market to drive better decisions. Evaluate solutions give you the time and confidence to turn understanding into insight, and insight into action: Evaluate Omnium - provides a complete, dynamic view of development risk and commercial return across the full clinical lifecycle, delivering game-changing insight into pharma asset potential. EvaluatePharma - the trusted global view of the pharmaceutical market's past, present and future performance with consensus forecasts to 2026, company financials, pipelines, deals and more. @EvaluatePharma EvaluateMedTech - tracks, benchmarks, and forecasts global performance for the medical device and diagnostic industry with consensus forecasts to 2024, company financials and more. Evaluate Custom Solutions - improve your strategic decision-making with customised solutions and deep insights that draw on our industry expertise and trusted commercial intelligence. Evaluate Vantage - award-winning, thought-provoking news and insights into current and future developments in the industry, underpinned by Evaluate's commercial intelligence. Explore Evaluate at www.evaluate.com. Twitter: @EvaluatePharma, @EvaluateVantage Locations: Evaluate Global HQ: 11-29 Fashion Street London E1 6PX, UK Evaluate Americas EvaluatePharma USA Inc. 60 State Street, Suite 1910 Boston, MA 02109 Evaluate Asia Pacific Evaluate Japan KK Akasaka Garden City 4F 4-15-1 Akasaka, Minato-ku Tokyo 107-0052, Japan